This hypothesis is further supported by the results of Boligano et al. (92) in which in 26 patients with late stage ADPKD urinary and serum NGAL levels were significantly higher in those with more advanced disease. This evidence concerns the gene LCN2 and autosomal dominant polycystic kidney disease.